Technical issues, regulatory hurdles, societal stagnancy. All three of these pose a threat to the advancement of personalized medicine. But perhaps the greatest issue, according to Xconomy's Luke Timmerman, is a lack of sufficient samples.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
Don't have a GenomeWeb or 360Dx account?Register for Free.
Nature News examines how science in the UK may fare as Boris Johnson, the next prime minister, pursues Brexit.
CNN reports that Immigration and Customs Enforcement in the US has expanded its DNA testing to seven sites along the southern border.
In PNAS this week: role for exosomes in neuronal circuit development, tuberculosis pathogen enzymes, and more.
Undoing Obamacare protections could affect people's willingness to undergo genetic testing, Sarah Lawrence College's Laura Hercher and the University of Iowa College of Law's Anya Prince write at BuzzFeed News.